APP下载

观察α-硫辛酸联合胰激肽原酶治疗糖尿病周围神经病变的疗效评价

2020-06-27闫海鹏

糖尿病新世界 2020年8期
关键词:临床疗效糖尿病

闫海鹏

[摘要] 目的 观察α-硫辛酸联合胰激肽原酶治疗糖尿病周围神经病变的疗效评价。方法 将来该院的68例糖尿病周围神经病变患者作为研究对象,该次研究2018年10月—2019年10月,按照入院顺序,将68例患者分为两组,即治疗组(n=34例)与对照组(n=34例),治疗组患者采用α-硫辛酸联合胰激肽原酶治疗,对照组患者采用α-硫辛酸治疗,治疗后评价临床治疗效果、不良反应发生率及患者血糖情况。结果 治疗效果:对照组治疗有效率远远低于治疗组,差异有统计学意义(P<0.05)。不良反应发生率:治疗组不良反应发生率相较对照组明显偏低,差异有统计学意义(P<0.05)。血糖情况:治疗组患者空腹血糖及餐后2 h血糖均优于对照组,差异有统计学意义(P<0.05)。结论 给予糖尿病周围神经病变患者α-硫辛酸联合胰激肽原酶治疗,既能提高治疗效果,又能改善患者血糖情况,确保治疗安全性。

[关键词] α-硫辛酸;胰激肽原酶;糖尿病;周围神经病变;临床疗效

[Abstract] Objective To observe the effect of α-lipoic acid combined with pancreatic kininogenase on diabetic peripheral neuropathy. Methods In the future, 68 patients with diabetic peripheral neuropathy will be taken as the research object. The study started in October 2018 and ended in October 2019. According to the order of admission, 68 patients were divided into two groups, that is, treatment group(n=34 cases) and control group(n=34 cases), patients in the treatment group were treated with α-lipoic acid combined with pancreatic kininogenase, patients in the control group were treated with α-lipoic acid, and the clinical treatment effect was evaluated after treatment. Incidence of adverse reactions and patient blood glucose. Results Therapeutic effect: The effective rate of treatment in the control group was much lower than that in the treatment group, with statistically significant difference (P<0.05). Incidence of adverse reactions: the incidence of adverse reactions in the treatment group was significantly lower than that in the control group, with statistically significant difference (P<0.05). Blood glucose: Fasting blood glucose and 2 h postprandial blood glucose was better in the treatment group than in the control group, with statistically significant differences(P<0.05). Conclusion The therapy of α-lipoic acid combined with pancreatic kininogenase in patients with diabetic peripheral neuropathy can not only improve the treatment effect, but also improve the blood glucose of the patient, and ensure the safety of treatment.

[Key words] α-lipoic acid; Pancreatic kininogenase; Diabetes; Peripheral neuropathy; Clinical efficacy

糖尿病周圍神经病变属于临床常见的糖尿病并发症,具体是指周围神经系统出现功能损害,进而对患者的感知功能和运动功能产生影响。患者发病后,临床症状以感觉缺失最为明显,同时患者会伴有肢体疼痛、麻木等现象,给患者生活质量及身心健康均带来严重影响[1-2]。目前,临床常采用α-硫辛酸对其进行治疗,虽然该药物对受损的周围神经组织具有修复效果,但是对于病情严重的患者,单独使用α-硫辛酸治疗,临床修复效果并不明显,针对这一现状,临床推出了α-硫辛酸联合胰激肽原酶治疗方式,该方式相较常规治疗而言,临床效果更为突出,为了进一步明确胰激肽原酶对糖尿病周围神经病变患者的临床疗效,故该次研究将2018年10月—2019年10月来该院的糖尿病周围神经病变患者作为研究对象,对患者分别采用α-硫辛酸及α-硫辛酸联合胰激肽原酶治疗后,评价临床治疗效果、不良反应发生率及患者血糖情况,报道如下。……

登录APP查看全文

猜你喜欢

临床疗效糖尿病
糖尿病知识问答
糖尿病知识问答
糖尿病知识问答
糖尿病知识问答
糖尿病知识问答
糖尿病知识问答
探讨氯吡格雷预防冠心病介入治疗心血管的临床疗效
131碘治疗甲亢患者的后期随访效果分析
枸橼酸咖啡因治疗早产儿原发性呼吸暂停临床分析
微创手术治疗胃溃疡42例临床分析